← Back to FilingsView Full SEC Filing
MRKMerck & Co., Inc.
Form 8-KTuesday, September 9, 2025➖High Impact
Merck & Co., Inc. Reports $6 Billion Public Debt Offering
financing
Summary
On September 9, 2025, Merck & Co., Inc. closed an underwritten public offering of $6,000,000,000 aggregate principal amount of Notes. This offering included six series of notes with maturities ranging from 2027 to 2055 and interest rates up to 5.700%. The Notes were issued under the Company's Registration Statement on Form S-3ASR and an indenture dated January 6, 2010.
Why It Matters
This significant debt offering provides Merck & Co., Inc. with substantial capital, which can be used for general corporate purposes, potentially funding operations, investments, or debt refinancing. Investors should note the terms and scale of this financing as it impacts the company's capital structure and future financial flexibility.
Filing Details
Reported Items
Item 8.01Other Events
Item 9.01Financial Statements and Exhibits
Additional Information
- CIK Number
- 0000310158
- Filing Date
- Tuesday, September 9, 2025
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- neutral